Article · 4 May 2026
ArticlePublished 17 May 2024
Outcomes of Irbesartan Hydrochlorothiazide Combined with Recombinant Human Brain Natriuretic Peptide on Cardiac Function, Immune Function and Intestinal Flora in Acute Heart Failure
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To investigate the effects of irbesartan hydrochlorothiazide combined with recombinant human brain natriuretic peptide on cardiac function, immune function and intestinal flora in subjects with acute heart failure. 100 subjects with acute heart failure admitted to our hospital from March 2021 to March 2022 were divided into 50 subjects in each group according to different intervention methods. The monotherapy group was handled with conventional therapy, and the combination therapy group was handled with irbesartan hydrochlorothiazide combined with recombinant human brain natriuretic peptide, clinical efficacy, cardiac function, serum myocardial enzymes, cardiac troponin I, immunological functioning, change of intestinal flora and adverse reactions in two groups were contrasted. The monotherapy group vs. the total effective rate of the combination therapy group was higher (92.00 % vs. 74.00 %) (p 0.05). Irbesartan hydrochlorothiazide combined with recombinant human brain natriuretic peptide can improve the therapeutic effect of acute heart failure, improve the subject’s cardiac function, reduce the myocardial injury, improve the body immunity, and regulate the intestinal flora structure, so as to promote the subject’s recovery.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Le Wang”
- BylineArticles whose byline prints “Li Feng”
- BylineArticles whose byline prints “Zhenxing Wang”